You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

individualized radiotherapy

Showing 1 - 25 of 7,074
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC (NSCLC) Trial in Canada, Japan, United States (iSABR, 25 Gray in 1 fraction for small peripheral tumors, iSABR, 50 Gray in

Completed
  • Non-small Cell Lung Cancer (NSCLC)
  • iSABR, 25 Gray in 1 fraction for small peripheral tumors
  • +5 more
  • Stanford, California
  • +3 more
Jul 27, 2022

Prostate Cancer Trial in Toronto (Transrectal APT Device or Transperineal Device will be used, TRUS probe)

Active, not recruiting
  • Prostate Cancer
  • Transrectal APT Device or Transperineal Device will be used
  • TRUS probe
  • Toronto, Ontario, Canada
    University Health Network
Oct 1, 2021

Early Metastasis in Cervical Cancer Patients After Radiotherapy

Not yet recruiting
  • Cervical Cancer
  • +4 more
  • external pelvic beam radiotherapy (EBRT) followed by individualized high-dose-rate intracavitary brachytherapy (HDR-ICBT)
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Oct 21, 2023

Low Grade Glioma Trial in Heidelberg (model-guided optimization of treatment plan, standard treatment plan, no optimization)

Not yet recruiting
  • Low Grade Glioma
  • model-guided optimization of treatment plan
  • standard treatment plan, no optimization
  • Heidelberg, Germany
    Department of Radiotherapy, University of Heidelberg
Jul 19, 2023

Stage III NSCLC Trial in Birmingham (Adaptive Radiotherapy, Non-Adaptive Radiotherapy, Chemotherapy)

Not yet recruiting
  • Stage III Non-small Cell Lung Cancer
  • Adaptive Radiotherapy
  • +3 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 3, 2022

Uterine Cervical Tumors Trial in Gent (treatment with EXIT-target volume)

Completed
  • Uterine Cervical Neoplasms
  • treatment with EXIT-target volume
  • Gent, Belgium
    Radiotherapy Department Ghent University Hospital
Dec 16, 2022

Oropharynx Cancer Trial in Ann Arbor (Carboplatin, Radiation Therapy, Paclitaxel)

Recruiting
  • Oropharynx Cancer
  • Ann Arbor, Michigan
  • +1 more
Feb 8, 2022

Patients Receiving Adjuvant Radiotherapy for Breast Cancer

Completed
  • Breast Cancer
    • Sacramento, California
      UC Davis Medical Center
    Oct 26, 2020

    Neoadjuvant Therapy Trial (standard long-term therapy, FOLFOX and standard long-term radiotherapy, FOLFIRI and standard

    Not yet recruiting
    • Neoadjuvant Therapy
    • standard long-term therapy
    • +5 more
    • (no location specified)
    Apr 22, 2022

    Prostate Cancer Trial in Sweden (Individualised therapy, Standard salvage therapy)

    Recruiting
    • Prostate Cancer
    • Individualised therapy
    • Standard salvage therapy
    • Göteborg, Sweden
    • +4 more
    Sep 17, 2021

    Artificial Intelligence in Functional Imaging for Individualized

    Recruiting
    • HNSCC
    • Observation
    • Berlin, Germany
      Department of Radiooncology and Radiotherapy, Charité - Universi
    Jan 13, 2022

    Breast Tumors Trial in United States (endocrine therapy alone without radiotherapy)

    Active, not recruiting
    • Breast Neoplasms
    • endocrine therapy alone without radiotherapy
    • Stanford, California
    • +12 more
    Dec 20, 2022

    Rectal Cancer Trial in Beijing (combination product, radiation, drug, procedure)

    Recruiting
    • Rectal Cancer
    • Concurrent Chemoradiotherapy Radiotherapy
    • +5 more
    • Beijing, China
      Department of Radiation Oncology, Cancer Institute and Hospital,
    Jun 6, 2021

    Cervix Cancer, Endometrial Cancer Trial in Stanford (FDG PET/CT, GCSF)

    Recruiting
    • Cervix Cancer
    • Endometrial Cancer
    • Stanford, California
      Stanford Cancer Institute Palo Alto
    Feb 11, 2022

    Locally Recurrent Nasopharyngeal Carcinoma Trial in Shanghai (Standardized CIRT, Individualized CIRT)

    Not yet recruiting
    • Locally Recurrent Nasopharyngeal Carcinoma
    • Standardized CIRT
    • Individualized CIRT
    • Shanghai, Shanghai, China
      Shanghai Proton and Heavy Ion Center
    Oct 16, 2020

    NSCLC Trial in London (Concurrent platinum-based chemo, Standard Radiotherapy, 60 Gy in 30 fractions., Functional Lung Avoidance

    Terminated
    • Non-small Cell Lung Cancer
    • Concurrent platinum-based chemotherapy
    • +2 more
    • London, Ontario, Canada
      London Health Sciences Centre
    Sep 23, 2019

    Nasopharyngeal Carcinoma Trial in Guangzhou (mobile platform or not mobile platform)

    Recruiting
    • Nasopharyngeal Carcinoma
    • mobile platform or not mobile platform
    • Guangzhou, Guangdong, China
      Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
    Apr 17, 2023

    Based on Molecular Typing of Medulloblastoma in Children

    Not yet recruiting
    • Medulloblastoma, Childhood
    • Prospective observational study, no intervention
    • (no location specified)
    Jun 4, 2022

    Esophageal Cancer Trial in Beijing (3DCRT)

    Recruiting
    • Esophageal Cancer
    • 3DCRT
    • Beijing, Beijing, China
      Department of Radiation Oncology, National Cancer Center/Nationa
    Sep 13, 2022

    Muscle-Invasive Bladder Carcinoma Trial in Herlev (Varian Ethos Adaptive Radiation Therapy)

    Recruiting
    • Muscle-Invasive Bladder Carcinoma
    • Varian Ethos Adaptive Radiation Therapy
    • Herlev, Denmark
      Herlev and Gentofte Hospital
    Nov 29, 2022

    Toward High Fidelity Adaptive Radiotherapy in the Thorax

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • CBCT-guided Adaptive Radiotherapy
    • (no location specified)
    Nov 30, 2022

    Nasopharyngeal Tumors Trial in Guangzhou (IMRT using individualized CTV, IMRT using traditional CTV, Gemcitabine and cisplatin

    Unknown status
    • Nasopharyngeal Neoplasms
    • IMRT using individualized CTV
    • +5 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Jun 13, 2020

    NSCLC Trial in Tübingen, Münich, Heidelberg (Photons)

    Recruiting
    • Non-small Cell Lung Cancer
    • Photons
    • Tübingen, Baden-Württemberg, Germany
    • +2 more
    Aug 19, 2022

    Classical Hodgkin Lymphoma Trial in Cologne (Tislelizumab)

    Not yet recruiting
    • Classical Hodgkin Lymphoma
    • Cologne, Germany
      1st Department of Medicine, Cologne University Hospital
    Aug 5, 2022

    Vulvar Cancer Individualized Scoring System (VCISS)

    Not yet recruiting
    • Vulvar Cancer
    • Machine learning-based prediction model
    • Alexandria, Egypt
    • +1 more
    Aug 22, 2023